Apoptosis induced by short hairpin RNA-mediated STAT6 gene silencing in human colon cancer cells

Chinese Medical Journal

Volumn 119, Issue 10, 2006, Pages 801-808

  Zhang, Ming Sheng ^a   Zhou, Yun Feng ^a   Zhang, Wen Jie ^b   Zhang, Xiao Lian ^c   Pan, Qin ^c   Ji, Xue Mei ^a   Luo, Zhi Guo ^a   Wu, Jian Ping ^a  

^a WUHAN UNIVERSITY   (China)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis; RNA interference; Short hairpin RNA; Signal transducer and activator of transcription 6; Tumor

Indexed keywords

LIPOSOME; MESSENGER RNA; PLASMID VECTOR; PROTEIN BAX; PROTEIN BCL 2; SHORT HAIRPIN RNA; STAT6 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL STRAIN HT29; COLON CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EUKARYOTE; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC SCREENING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR BIOLOGY; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 33744474042     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200605020-00002     Document Type: Article

References (42)

1. Gilman AG, Simon MI, Bourne HR, Harris BA, Long R, Ross EM, et al Overview of the alliance for cellular signaling. Nature 2002; 420: 703-706.
2. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264:1415-1421.
3. Ihle JN, Kerr IM. Jaks and Slats in signaling by the cytokine receptor superfamily. Trends Genet 1995; 11: 3951-3963.
4. Schindler C, Darnell JE. Transcriptional responses to polypeptide ligands: the Jak-STAT pathway. Annu. Rev Biochem 1995; 64: 621-651.
5. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, et al. Essential role of Stat6 in IL-4 signaling. Nature 1996; 380:627-630.
6. Takeda K, Kamanaka M, Tanaka T, Kishimoto T, Akira S. Impaired IL-13-mediated functions of macrophages in Stat6-deficient mice. J Immunol 1996; 157: 3220-3222.
7. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. Stat6 is required for mediating responses to IL-4 and for the development if Th2 cells. Immunity 1996; 4: 313-319.
8. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al. Lack of IL-4-induced Th2 responses and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630-633.
9. Gooch JL, Christy B, Yee D. STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. Neoplasia 2002; 4: 324-331.
10. Skinnider BF, Elia AJ, Gascoyne RD. Signal transduer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2002; 99: 618-626.
11. Pisani P, Parkin DM, Farley J. Estimates of the worldwide mortality from eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606.
12. Gudkov AV, Zelnick CR, Kazarov AR, Thimmapaya R, Suttle DP, Beck WT et al. Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. Proc Natl Acad Sci 1993; 90: 3231-3235.
13. Collins FS, Green ED, Guttmacher AE, Guyer MS. A vision for the future of genomic research. Nature 2003; 422: 835-847.
14. Novina CD, Sharp PA. The RNAi revolution. Nature 2004; 430: 161-164.
15. Matzke M, Matzke A, Kooter MJ. RNA: guiding gene silencing. Science 2001; 293: 1980-1983.
16. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature 1998; 391:806-811.
17. Ngo H, Tschudi C, Gull K, Ullu E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Aced Sci USA 1998; 95:14687-14692.
18. Kennerdell JR, Carthew RW. Heritable gene silencing in Drosophila using double-stranded RNA. Nat Biotechnol 2000;17:896-898.
19. Yu JY, DeRuiter SL, Turner DL. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 2002; 99:6047-6052.
20. Kisielow M, Kleiner S, Nagasawa M, Faisal A, Nagamine Y. Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA. Biochem J 2002; 363 (Pt 1):1-5.
21. Tuschl T. Expanding small RNA interference. Nat Biotechnol 2002; 20: 446-448.
22. Agami R. RNAi and related mechanisms and their potential use for therapy. Curr Opin Chem Biol 2002; 6: 829-834.
23. Krutzik PO, Nolan GP. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry A 2003; 55: 61-70.
24. Krutzik PO, Irish JM, Nolan GP, Perez OD. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin Immunol 2004; 110:206-221.
25. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539-542.
26. Linehan LA, Warren WD, Thompson PA, Grusby MJ, Berton MT. Stat6 is required for IL-4-mediated germline Ig gene transcription and switch recombination. J Immunol 1998; 161: 302-310.
27. Tomkinson A, Duez C, Lahn M, Gelfand EW. Adoptive transfer of T cells induces airway hyperresponsiveness independently of airway eosinophilia but in a signal transducer and activator of transcription 6-dependent manner. J Allergy Clin Immunol 2002; 109: 810-816.
28. Ni Z, Lou W, Lee SO. Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. J Urol 2002; 167: 1859-1862.
29. Suzanne O, Michael JG, Virginia KC. Cutting edge: STAT6-deficient mice have enhanced tumor immunity to primary and metastatic mammary carcinoma. J Immunol 2000; 165: 6015-6019.
30. Zhang WJ, Koltun WA, Thompson JL, Tilberg AF, Galka E, Poritz LS, et al. Human B lymphoblast cell lines defective of Stat6 signaling produce high levels of proinflammatory cytokines IL-12,TNF-α andIFN-γ. Int J Oncology 2004; 24: 447-453.
31. null phenotype human lymphocytes exhibit increased apoptosis. J Surg Res 2004; 122: 14-20.
32. Dorsett Y, Tuschl T. siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 2004; 3: 318-329.
33. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute 2, a link between genetic and biochemical analyses of RNAi. Science 2001; 293:1146-1150.
34. Elbashir SM, Harborth J, Weber K, Tuschl T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 2002; 26:199-213.
35. Gan HZ, Zhang GZ, Zhao JS, Zhang FC, Bu LS, Yang SJ, et al. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Chin Med J 2005; 118:893-902.
36. Miyagishi M, Taira K. U6 promoter driven shRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 2002; 20:497-500.
37. Czauderna F, Fechtner M, Aygun H, Arnold W, Klippel A, Giese K, et al. Functional studies of the PI(3)-kinase signaling pathway employing synthetic and expressed shRNA. Nucleic Acid Res 2003; 31:670-682.
38. Reed JC. Bcl-2 family proteins. Oncogene 1998; 17: 3225-3236.
39. Gross A, McDonnell JM, Korsmeyer S. Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899-1911.
40. Oltvai ZN, Millman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
41. Whitte E. Life, death, the pursuit of apoptosis. Genes Dev 1996; 10: 1-15.
42. Levy P, Robin H, Bertrand F, Komprobst M, Capeau J. Butyrate-treated colonic Caco-2 cells exhibit defective integrin-mediated signaling together with increased apoptosis and differentiation. J Cell Physiol 2003; 197: 336-347.